Strategic divestment of Silicones to Bluestar
Majority of Silicones division sold to China National Bluestar via redemption of Bluestar's 338 million shares; no cash payment. Transaction expected to close end-April/May subject to EGM (9 Mar) and lender approvals. Anticipated benefits: simplifies Elkem into a focused Silicon Products + Carbon Solutions pure-play, reduces capital intensity, and enables targeted capital allocation and M&A.
Underwritten equity and balance sheet actions
Pre-commitments and underwriting from major investors (Folketrygdfondet, Must Invest, DNB Asset Management, Nordea Investment Management, Perestroika) for a NOK 1.5 billion equity raise to follow the transaction; pro forma net interest-bearing debt expected ~NOK 8.3 billion and pro forma leverage ~3.6x EBITDA after the equity raise.
Q4 operational cash generation
Cash flow from operations in Q4 was NOK 829 million, showing improvement vs prior quarters driven by lower CapEx and positive working capital changes.
Solid Q4 headline EBITDA and margins despite weak markets
Group Q4 EBITDA NOK 890 million with an EBITDA margin of 12%. Excluding Silicones, Q4 operating income ~NOK 4.0 billion and EBITDA NOK 485 million (margin ~12%), indicating operational resilience.
Silicones division profitability improvement
Silicones delivered EBITDA of ~NOK 400 million in Q4, up ~6% YoY, primarily driven by cost improvements and higher sales prices in Asia Pacific late in the year.
Cost and efficiency improvements across divisions
Management highlighted ongoing raw material and operational cost reductions that partly offset weak demand and lower sales prices across Silicon Products and Carbon Solutions.
Favorable ferrosilicon price impact from EU safeguard measures
Following EU safeguard measures, ferrosilicon reference prices in the EU were up approximately 20% since implementation, supporting Silicon Products' outlook.
Strong historical performance and clear outlook targets
Since 2020, Elkem delivered a compound annual growth in operating income of ~5% and an EBITDA margin of ~16% (excluding Silicones, operating income CAGR ~6% and EBITDA margin ~21%). Management expects underlying top-line growth >10% in 2026 vs 2025 for the remaining business and lower ongoing annual investments (~NOK 1.0 billion).